missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. CD279 (PD-1) Mouse anti-Human, Brilliant Ultraviolet 737, Clone: EH12.1 (also known as EH12), BD Horizon™
  7. 17217894

CD279 (PD-1) Mouse anti-Human, Brilliant Ultraviolet 737, Clone: EH12.1 (also known as EH12), BD Horizon™

Mouse Monoclonal Antibody

Brand:  BD Biosciences 612792

2326.18 SEK valid until 2025-12-31
Use promo code "25339" to get your promotional price.

 View more versions of this product

Product Code. 17217894

  • 2330.00 SEK / 25 tests

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

CD279 (PD-1) Monoclonal antibody specifically detects CD279 (PD-1) in Human samples. It is validated for Flow cytometry.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CD279 (PD-1)
Monoclonal
Brilliant Ultraviolet 737
Mouse
Affinity Purified
RUO
Human
IgG1 Îş
Flow Cytometry
EH12.1 (also known as EH12)
Aqueous buffered solution containing ≤0.09% sodium azide.
Human PD-1 Recombinant Protein
25 Tests
Primary
Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title
CD279 (PD-1) Mouse anti-Human, Brilliant Ultraviolet 737, Clone: EH12.1 (also known as EH12), BD Horizon™ > 25 tests; BUV737

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.